IT1396556B1 - Uso di memantina per il trattamento di disturbi dell umore - Google Patents

Uso di memantina per il trattamento di disturbi dell umore

Info

Publication number
IT1396556B1
IT1396556B1 ITMI2009A000174A ITMI20090174A IT1396556B1 IT 1396556 B1 IT1396556 B1 IT 1396556B1 IT MI2009A000174 A ITMI2009A000174 A IT MI2009A000174A IT MI20090174 A ITMI20090174 A IT MI20090174A IT 1396556 B1 IT1396556 B1 IT 1396556B1
Authority
IT
Italy
Prior art keywords
distorbers
memantin
humor
treatment
Prior art date
Application number
ITMI2009A000174A
Other languages
English (en)
Inventor
Gino Serra
Original Assignee
Serra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serra filed Critical Serra
Priority to ITMI2009A000174A priority Critical patent/IT1396556B1/it
Priority to EP10151616.9A priority patent/EP2218450B1/en
Publication of ITMI20090174A1 publication Critical patent/ITMI20090174A1/it
Application granted granted Critical
Publication of IT1396556B1 publication Critical patent/IT1396556B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ITMI2009A000174A 2009-02-11 2009-02-11 Uso di memantina per il trattamento di disturbi dell umore IT1396556B1 (it)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ITMI2009A000174A IT1396556B1 (it) 2009-02-11 2009-02-11 Uso di memantina per il trattamento di disturbi dell umore
EP10151616.9A EP2218450B1 (en) 2009-02-11 2010-01-26 Memantine for treating bipolar mood disorders resistant to conventional treatments

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI2009A000174A IT1396556B1 (it) 2009-02-11 2009-02-11 Uso di memantina per il trattamento di disturbi dell umore

Publications (2)

Publication Number Publication Date
ITMI20090174A1 ITMI20090174A1 (it) 2010-08-12
IT1396556B1 true IT1396556B1 (it) 2012-12-14

Family

ID=41061215

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI2009A000174A IT1396556B1 (it) 2009-02-11 2009-02-11 Uso di memantina per il trattamento di disturbi dell umore

Country Status (2)

Country Link
EP (1) EP2218450B1 (it)
IT (1) IT1396556B1 (it)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI678202B (zh) * 2016-12-14 2019-12-01 陸汝斌 組合物用於製備治療酒癮或酒精濫用之藥物的用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002045710A1 (en) 2000-12-07 2002-06-13 Neuromolecular Inc. Methods for treating neuropsychiatric disorders with nmda receptor antagonists
AU2004251636B2 (en) * 2003-05-27 2006-11-09 Merz Pharma Gmbh & Co. Kgaa Combination of an NMDA receptor antagonist and a selective serotonin reuptake inhibitor for the treatment of depression and other mood disorders
TW200531680A (en) * 2004-03-03 2005-10-01 Merz Pharma Gmbh & Co Kgaa Therapy using 1-aminocyclohexane derivatives for the treatment of behavioral disorders associated with alzheimer's disease
CN101374525A (zh) * 2004-09-23 2009-02-25 莫茨药物股份两合公司 美金刚治疗儿童行为障碍
TW200819458A (en) 2006-06-23 2008-05-01 Merz Pharma Gmbh & Co Kgaa Metabotropic glutamate receptor modulators

Also Published As

Publication number Publication date
ITMI20090174A1 (it) 2010-08-12
EP2218450B1 (en) 2017-04-05
EP2218450A1 (en) 2010-08-18

Similar Documents

Publication Publication Date Title
SMT201600254B (it) Procedimento per la preparazione di idromagnesite
HRP20181608T1 (hr) Korištenje inhibitora pde7 u liječenju bolesti kretanja
SMAP200900085A (it) 3-imidazolil-indoli per il trattamento di malattieproliferative
SMT201400008B (it) Uso di betanecolo per il trattamento di xerostomia
BR112012013260A2 (pt) dispositivo usado para o tratamento de rinite através de iluminação bioestimulativa
BRPI1013698A2 (pt) métodos para tratamento com o uso de terapia de combinação
DK2504005T3 (da) Anvendelse af 1,3-diphenylprop-2-en-1-on-derivater til behandling af lever-sygdomme
BR112014013843A2 (pt) uso de dispositivos para o tratamento de doenças neurológicas
BR112012004836A2 (pt) pirazinilpiridinas úteis para o tratamento de doenças proliferativas
BRPI1009783A2 (pt) compostos para o tratamento de distúrbios metabólicos.
SMT201600041B (it) Agenti terapeutici 713
BRPI0915905A2 (pt) uso de derivados de pirimidilaminobenzamida para o tratamento de fibrose
BR112012001837A2 (pt) uso de fulvestrant
IT1403587B1 (it) Composizione per il trattamento di disordini metabolici
BRPI0907956A2 (pt) Uso de ranolazina para o tratamento de doenças cardiovasculares
IT1395596B1 (it) Procedimento per la preparazione di sitagliptin
IT1397000B1 (it) Uso di un preparato basato sulla nifedipina per il trattamento del vaginismo
IT1394299B1 (it) Procedimento per la preparazione di sevelamer
IT1396556B1 (it) Uso di memantina per il trattamento di disturbi dell umore
IT1394292B1 (it) Procedimento per la sintesi di pregabalina
IT1397522B1 (it) Uso di una combinazione per il trattamento dell'osteoartrosi
IT1403982B1 (it) Dispositivo per il trattamento delle stenosi esofagee
IT1398032B1 (it) Transferrina per il trattamento di malattie autoimmuni.
IT1391776B1 (it) Procedimento per la preparazione di dexlansoprazolo
IT1398273B1 (it) Procedimento per la preparazione di 14-bromo daunomicina